Stratos Wealth Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.6M | Buy |
9,455
+2,907
| +44% | +$497K | 0.02% | 630 |
|
|
2025
Q4 | $1.11M | Buy |
6,548
+1,033
| +19% | +$168K | 0.01% | 739 |
|
|
2025
Q3 | $796K | Sell |
5,515
-876
| -14% | -$120K | 0.01% | 841 |
|
|
2025
Q2 | $809K | Sell |
6,391
-544
| -8% | -$66.8K | 0.01% | 769 |
|
|
2025
Q1 | $887K | Sell |
6,935
-1,167
| -14% | -$158K | 0.01% | 707 |
|
|
2024
Q4 | $1.07M | Sell |
8,102
-1,772
| -18% | -$249K | 0.02% | 673 |
|
|
2024
Q3 | $1.44M | Buy |
9,874
+111
| +1% | +$16.1K | 0.02% | 550 |
|
|
2024
Q2 | $1.34M | Sell |
9,763
-7,222
| -43% | -$964K | 0.02% | 558 |
|
|
2024
Q1 | $2.33M | Buy |
16,985
+6,341
| +60% | +$866K | 0.04% | 416 |
|
|
2023
Q4 | $1.45M | Sell |
10,644
-1,743
| -14% | -$213K | 0.03% | 497 |
|
|
2023
Q3 | $1.51M | Buy |
12,387
+24
| +0.2% | +$3.05K | 0.03% | 441 |
|
|
2023
Q2 | $1.57M | Buy |
12,363
+1,751
| +17% | +$227K | 0.04% | 401 |
|
|
2023
Q1 | $1.37M | Sell |
10,612
-2,367
| -18% | -$310K | 0.04% | 400 |
|
|
2022
Q4 | $1.7M | Buy |
12,979
+95
| +0.7% | +$12.3K | 0.04% | 377 |
|
|
2022
Q3 | $1.51M | Sell |
12,884
-1,674
| -11% | -$208K | 0.04% | 374 |
|
|
2022
Q2 | $1.71M | Sell |
14,558
-2,438
| -14% | -$289K | 0.04% | 349 |
|
|
2022
Q1 | $2.21M | Buy |
16,996
+667
| +4% | +$86.9K | 0.05% | 335 |
|
|
2021
Q4 | $2.49M | Sell |
16,329
-2,005
| -11% | -$310K | 0.06% | 303 |
|
|
2021
Q3 | $2.96M | Sell |
18,334
-87
| -0.5% | -$14.6K | 0.08% | 253 |
|
|
2021
Q2 | $3.02M | Buy |
18,421
+1,264
| +7% | +$195K | 0.08% | 256 |
|
|
2021
Q1 | $2.58M | Sell |
17,157
-1,373
| -7% | -$218K | 0.07% | 249 |
|
|
2020
Q4 | $2.81M | Buy |
18,530
+229
| +1% | +$32.7K | 0.08% | 231 |
|
|
2020
Q3 | $2.48M | Buy |
18,301
+3,322
| +22% | +$451K | 0.08% | 237 |
|
|
2020
Q2 | $2.05M | Buy |
14,979
+4,573
| +44% | +$583K | 0.07% | 252 |
|
|
2020
Q1 | $1.12M | Buy |
10,406
+624
| +6% | +$71.8K | 0.05% | 305 |
|
|
2019
Q4 | $1.18M | Sell |
9,782
-488
| -5% | -$54.4K | 0.05% | 348 |
|
|
2019
Q3 | $1.02M | Buy |
10,270
+200
| +2% | +$20.9K | 0.04% | 364 |
|
|
2019
Q2 | $1.1M | Sell |
10,070
-357
| -3% | -$38K | 0.05% | 343 |
|
|
2019
Q1 | $1.17M | Sell |
10,427
-541
| -5% | -$59.3K | 0.05% | 327 |
|
|
2018
Q4 | $1.06M | Sell |
10,968
-1,059
| -9% | -$112K | 0.05% | 316 |
|
|
2018
Q3 | $1.47M | Buy |
12,027
+2,510
| +26% | +$296K | 0.07% | 266 |
|
|
2018
Q2 | $1.04M | Sell |
9,517
-2,573
| -21% | -$275K | 0.05% | 353 |
|
|
2018
Q1 | $1.29M | Buy |
12,090
+2,298
| +23% | +$255K | 0.05% | 307 |
|
|
2017
Q4 | $1.05M | Sell |
9,792
-1,404
| -13% | -$150K | 0.05% | 339 |
|
|
2017
Q3 | $1.25M | Sell |
11,196
-213
| -2% | -$22.8K | 0.06% | 296 |
|
|
2017
Q2 | $1.18M | Buy |
11,409
+2,883
| +34% | +$284K | 0.06% | 265 |
|
|
2017
Q1 | $833K | Buy |
8,526
+2,517
| +42% | +$241K | 0.05% | 312 |
|
|
2016
Q4 | $532K | Buy |
6,009
+1,584
| +36% | +$144K | 0.03% | 371 |
|
|
2016
Q3 | $427K | Buy |
4,425
+282
| +7% | +$26.8K | 0.03% | 394 |
|
|
2016
Q2 | $355K | Buy |
4,143
+438
| +12% | +$39.3K | 0.03% | 407 |
|
|
2016
Q1 | $322K | Sell |
3,705
-1,884
| -34% | -$168K | 0.03% | 396 |
|
|
2015
Q4 | $630K | Buy |
5,589
+2,997
| +116% | +$325K | 0.05% | 255 |
|
|
2015
Q3 | $262K | Sell |
2,592
-1,104
| -30% | -$132K | 0.03% | 416 |
|
|
2015
Q2 | $455K | Buy |
3,696
+1,008
| +38% | +$121K | 0.06% | 274 |
|
|
2015
Q1 | $307K | Buy |
+2,688
| New | +$296K | 0.04% | 419 |
|
Other funds holding IBB
CB
Stratos Wealth Partners's IBB Position: Q1 2026 in Review
Stratos Wealth Partners increased its iShares Biotechnology ETF (IBB) stake by 44% in Q1 2026, buying an estimated $497K and bringing the position to 9,455 shares worth $1.6M. The position accounts for 0.02% of the portfolio, ranked #630.
Stratos Wealth Partners first reported a position in IBB in Q1 2015 and has held it in 45 quarters since. The position peaked at $3.02M in Q2 2021. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Stratos Wealth Partners held 9,455 shares of iShares Biotechnology ETF worth $1.6M as of Q1 2026.
- Stratos Wealth Partners bought 2,907 iShares Biotechnology ETF shares in Q1 2026, an estimated $497K.
- iShares Biotechnology ETF made up 0.02% of Stratos Wealth Partners's portfolio in Q1 2026, its #630 holding.
- Stratos Wealth Partners first reported a position in iShares Biotechnology ETF in Q1 2015 and has held it in 45 quarters since.
- Stratos Wealth Partners's iShares Biotechnology ETF position peaked at $3.02M in Q2 2021.
- 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.